Biogen Idec Inc. (Nasdaq: BIIB) reports Q3 EPS of $0.58, versus the consensus of $0.65. Revenues came in at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE